Longitudinal stent deformation: Insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database

EuroIntervention

Volumn 8, Issue 2, 2012, Pages 196-204

  Mamas, Mamas A ^a,b   Williams, Paul D ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

FDA MAUDE database; Longitudinal stent deformation; PCI complications; Stent platforms

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DISEASE PREDISPOSITION; EMERGENCY SURGERY; FACTUAL DATABASE; HUMAN; IATROGENIC DISEASE; LONGITUDINAL STENT DEFORMATION; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOLOGICAL ANATOMY; STENT THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; DATABASES, FACTUAL; HUMANS; STENTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84865611916     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I2A33     Document Type: Article

References (13)

1. Mortier P, De Beule M. Stent design back in the picture: an engineering perspective on longitudinal stent compression. EuroIntervention. 2011;7:773-5.
2. Prabhu S, Schikorr T, Mahmoud T, Jacobs J, Potgieter A, Simonton C. Engineering assessment of the longitudinal compression behaviour of contemporary coronary stents. EuroIntervention. 2011 Nov 7. [Epub ahead of print].
3. Hanratty CG, Walsh SJ. Longitudinal compression: a "new" complication with modern coronary stent platfroms - time to think beyond deliverability? EuroIntervention. 2011;7:872-877.
4. Williams PD, Mamas MA, Morgan KP, El-Omar M, Clarke B, Bainbridge A, Fath-Ordoubadi F, Fraser DG. Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms. EuroIntervention. 2011 Nov 4. [Epub ahead of print].
5. Robinson AD, Schreiber TL, Grines CL. Deformation, Longitudinal Shortening, and Accordion of an Ion Stent. J Interv Cardiol. 2011;24:493-5.
6. Ormiston JA, Webber B, Webster MW. Stent Longitudinal Integrity. Bench Insights Into a Clinical Problem. JACC Cardiovasc Interv. 2011;4:1310-1317.
7. Allocco DJ, Jacoski MV, Huibregtse B, Mickley T, Dawkins KD. Platinum Chromium Stent Series™ The TAXUS™ Element™ (ION™), PROMUS Element™ and OMEGA™ Stents. J Interv Cardiol. 2011;6:134-141.
8. Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. J Am Coll Cardiol. 2011;57: 1700-8.
9. Kereiakes DJ, Cannon LA, Feldman RL, Popma JJ, Magorien R, Whitbourn R, Dauber IM, Rabinowitz AC, Ball MW, Bertolet B, Kabour A, Foster MC, Wang JC, Underwood P, Dawkins KD. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial. J Am Coll Cardiol. 2010;56:264-71.
10. Cannon LA, Kereiakes DJ, Mann T, Popma JJ, Mooney MR, Mishkel GJ, Lee TC, Wilson BH, Stuckey TD, Orlow S, Orlow S, McGarry T, Ring ME, Kellett MA, Underwood P, Dawkins KD. A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial. EuroIntervention. 2011;6:920-7.
11. Meredith IT, Whitbourn R, Scott D, El-Jack S, Zambahari R, Stone GW, Teirstein PS, Starzyk RM, Allocco DJ, Dawkins KD. PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses. EuroIntervention. 2011;7:84-90.
12. Allocco DJ, Cannon LA, Britt A, Heil JE, Nersesov A, Wehrenberg S, Dawkins KD, Kereiakes DJ. A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program. Trials. 2010;11:1.
13. 2005. Management of Safety Information from Clinical Trials (Report of CIOMS Working Group VI): WHO Press.